Methylprednisolone: Likely an Effective Treatment in Acute Respiratory Distress Syndrome

Crit Care Med. 2019 Apr;47(4):e374-e375. doi: 10.1097/CCM.0000000000003572.

Authors

G Umberto Meduri¹, Bram Rochwerg, Djillali Annane, Stephen M Pastores; Corticosteroid Guideline Task Force of SCCM and ESICM

Collaborators

Corticosteroid Guideline Task Force of SCCM and ESICM:
Wiebke Arlt, Josef Briegel, Albertus Beishuizen, Robert A Balk, Joseph Carcillo, Mirjam Christ-Crain, Mark S Cooper, Paul E Marik, Keith M Olsen, Sophia C Rodgers, James A Russell, Greet Van den Berghe

Affiliation

¹ Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, Memphis Veterans Affairs Medical Center, Memphis, TN; Division of Critical Care, Department of Medicine, McMaster University, Hamilton, ON, Canada; General ICU Department, Raymond Poincaré Hospital (APHP), Health Science Centre Simone Veil, Université Versailles SQY-Paris Saclay, Versailles, France; Department of Anesthesiology and Critical Care Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.

PMID: 30882439
DOI: 10.1097/CCM.0000000000003572

No abstract available

Publication types

Letter
Comment

MeSH terms

Glucocorticoids
Humans
Methylprednisolone
Respiratory Distress Syndrome*
Respiratory Insufficiency*
Tidal Volume

Substances

Glucocorticoids
Methylprednisolone